Science Explorer Back to mapMap
Discussion
Researcher · Texas Tech University Health Sciences Center · United States

C. Patrick Reynolds

C. Patrick Reynolds publishes mostly in Molecular Biology, Neurology and Oncology, on topics such as Neuroblastoma Research and Treatments, Retinoids in leukemia and cellular processes and Cancer therapeutics and mechanisms.

ORCID 0000-0002-2827-8536 OpenAlex
World rank
#132,338
of 7,710,434 ranked researchers
Rank in United States
#50,217
of 1,627,098
Works
572
Citations
29k
Citations per work
51.2
h-index
84
i10-index 279Top 0.5% in Molecular Biology
C. Patrick Reynolds

What does C. Patrick Reynolds research?

C. Patrick Reynolds's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (26%), Immunology and Microbiology (3%).

Life Sciences: 256 works · 44.8% of their workBiochemistry, Genetics and Molecular Biology: 241 works · 42.2% of their workMolecular Biology: 184 works · 32.2% of their workCancer Research: 39 works · 6.9% of their workGenetics: 18 works · 3.1% of their workImmunology and Microbiology: 15 works · 2.6% of their workImmunology: 15 works · 2.6% of their workEverything else: 168 works · 29.3% of their workHealth Sciences: 148 works · 25.9% of their workMedicine: 148 works · 25.9% of their workNeurology: 105 works · 18.4% of their workOncology: 43 works · 7.5% of their workTHEIR WORKC. PatrickReynolds572works
Life Sciences45%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology24142.2%
    2. Immunology and Microbiology152.6%
  2. Everything else16829.3%
    1. Medicine14825.9%
  1. 1Molecular Biology32% of their works
  2. 2Neurology18% of their works
  3. 3Oncology8% of their works
  4. 4Cancer Research7% of their works
  5. 5Genetics3% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe C. Patrick Reynolds's research?

The keywords of their largest research topics: Immunotherapy, ALK, Neuroblastoma, Acute Promyelocytic Leukemia, DNA, Retinoic Acid, Topoisomerases and HIF-1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Immunotherapy2452 topics
  2. ALK2241 topic
  3. Neuroblastoma2241 topic
  4. Acute Promyelocytic Leukemia751 topic
  5. DNA751 topic
  6. Retinoic Acid751 topic
  7. Topoisomerases751 topic
  8. HIF-1671 topic
  9. Warburg Effect671 topic
  10. Gene Therapy301 topic
  11. Viral Vectors301 topic
  12. Apoptosis291 topic
  13. Cell Death291 topic
  14. Glioblastoma211 topic
  15. Temozolomide211 topic
  16. Acute Lymphoblastic Leukemia201 topic
  17. Childhood Cancer201 topic

Where does C. Patrick Reynolds work?

C. Patrick Reynolds's main affiliation in the publication record is Texas Tech University Health Sciences Center, United States.

How many publications and citations does C. Patrick Reynolds have?

OpenAlex counts 572 works and 29,311 citations for C. Patrick Reynolds, an h-index of 84, ranking #132,338 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about C. Patrick Reynolds. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.